血浆富含甘油三酯脂蛋白残粒与动脉粥样硬化
被引量:2
摘要
富含甘油三酯脂蛋白残粒已成为目前心血管疾病基础与临床研究的一个热点,其作为心血管事件的一个独立危险因素以及在动脉粥样硬化发生发展过程中所扮演的重要角色已逐渐被广泛认知。本文就其性质及测定、与动脉粥样硬化的关系、降脂治疗对其影响以及临床意义等方面的研究进展作一综述。
出处
《中国动脉硬化杂志》
CAS
CSCD
2006年第9期813-816,共4页
Chinese Journal of Arteriosclerosis
参考文献39
-
1Nakamura T,Kugiyama K.Triglycerides and remnant particles as risk factors for coronary artery disease[J].Curr Atheroscler Rep,2006,8 (2):107-110
-
2Yarnell JW,Patterson CC,Sweetnam PM,Thomas HF,Bainton D,Elwood PC,et al.Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-up of Caerphilly and Speedwell Cohorts[J].Arterioscler Thromb Vasc Biol,2001,21 (8):1 340-345
-
3Cohn JS,Marcoux C,Davignon J.Detection,quantification,and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins[J].Arterioscler Thromb Vasc Biol,1999,19 (10):2 474-486
-
4马百坤,庄一义.高富含三酰甘油脂蛋白残粒是动脉硬化的危险因素[J].临床检验杂志,2004,22(1):60-62. 被引量:1
-
5Nakajima K,Okazaki M,Tanaka A,Pullinger CR,Wang T,Nakano T,et al.Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apoB-100 and apoA-I[J].J Clin Ligand Assay,1996,19 (3):177-183
-
6McNamara JR,Shah PK,Nakajima K,Cupples LA,Wilson PW,Ordovas JM,Schaefer EJ.Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study[J].Clin Chem,1998,44 (6 Pt 1):1 224-232
-
7Bittner V,Tripputi M,Hsia J,Gupta H,Steffes M.Remnant-like lipoproteins,hormone therapy,and angiographic and clinical outcomes:The Women's Angiographic Vitamin & Estrogen Trial[J].Am Heart J,2004,148 (2):293-299
-
8Twickler TB,Dallinga-Thie GM,de Valk HW,Schreuder PC,Jansen H,Cabezas MC,et al.High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia[J].Arterioscler Thromb Vasc Biol,2000,20 (11):2 422-427
-
9Sauvage-Nolting PR,Buirma RJ,Hutten BA,Kastelein JJ.Baseline lipid values partly determine the response to high-dose simvastatin in patients with familial hypercholesterolemia[J].Atherosclerosis,2002,164 (2):347-354
-
10Sauvage Nolting PR,Twickler MB,Dallinga-Thie GM,Buirma RJ,Hutten BA,Kastelein JJ.Elevated remnant-like particles in heterozygous familial hypercholesterolemia and response to statin therapy[J].Circulation,2002,106 (7):788-792
二级参考文献23
-
1胡大一,刘晓惠.糖尿病与冠心病之间的关系[J].现代康复,1999,3(12):1452-1453. 被引量:18
-
2[1]Collins P,Stevenson J C,Mosca L.Spotlight on gender[J].Cardiovascular Research,2002,53(3):535-537.
-
3[2]Cohn J S,Marcoux C,Davignon J O R.Detection,quantificaton,and characterization of potentially a therogenic triglyceride -rich remnant lipoproteins[J]. Arterioscler Thromb Vasc Biol,1999,19(10):2474-2486.
-
4[3]Chan D C,Watts G F,Barrett P H,et al.Relation ships between cholesterol homoeostasis and triacylglyceral-rich lipoprotein remnant metabolism in the metabolic syndrome[J].Clin Sci(Lond),2003,104(4):383-388.
-
5[4]Rifai N,Warnick G R,Dominiczak M H.Handbook of lipoprotein testing[M].AACC press,1997,452-454.
-
6[5]Kawano M,Shinomiya M,Knzaki T,et al.Slow β migrating lipoprotein:an atherogenic subclass of low density lipoproteins[J].Clin Biochem,1996,29(3):241-248.
-
7[6]Kandoussi A,Cachera C,Paray D,et al.Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay;apoB with apoC-Ⅲ and apoB with apoE[J].J Immunoassay,1991,12(3):305-323.
-
8[7]Nakajima K,Okazaki M,Tanaka A,et al.Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apoB-100 and apoA1[J].J Clin Ligand Assay,1996,19:177-183.
-
9[8]Koji K,Koji O,Kolisuke O,et al.Highly sensitive cholesterol assay with enzymatic cycling applied to measurement of remnant lipoprotein-cholesterol in serum[J]. Clin Chem,2002,48(5):737-741.
-
10[9]Huff M W,Evans A J,Sawyez C G,et al.Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins: Comparison of very low density lipoprotein from subjects with type Ⅲ,Ⅳ and Ⅴ hyper lipoproteinemias[J].Arterioscler Tromb,1991,11(2):221-233.
同被引文献25
-
1郑平,祁哲.脂残粒的基础与临床[J].中国分子心脏病学杂志,2005,5(1):430-433. 被引量:2
-
2Twickler T B,Dallinga-Thie G M,Cohn J S,et al.Elevated remnant-like particle cholesterol concentration; a characteristic feature of the atherogenic lipoprotein phenotype[J].Circulation,2004,109(16):1918-1925.
-
3Ohara N,Takeichi S,Nait o Y,et al.Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium-dependent vasorelaxation[J].Clin Chem Acta,2003,338(1-2):151 -156.
-
4Kawakami A,Tanaka A,Nakajma K,et al.Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions[J].Circ Res,2002,91(3):263-271.
-
5Doi H,Kugiyama K,Oka H,et al.Remnant lipoprotein induce proatherothrom bogenic molecules in endothelial cells through a redox sensitive mechanism[J].Circulation,2000,102(6):670-676.
-
6Yamazaki M,Uchiyama S,Xiong Y,et al.Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents[J].Thromb Res,2005,115 (3):211-218.
-
7Kawakami A,Tanaka A,Chiba T,et al.Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth fact or receptor transactivation[J].Circulation,2003,108(21):2679-2688.
-
8于本章.脂蛋白残粒胆同醇与高密度脂蛋白胆固醇比值在冠心病中的应用.医学检验与临床,2009,20(3):97-97.
-
9Nakajima K,Okazaki M,Tanaka A,et al.Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apoB-100 and apoA1[J].Clin Ligand Assay,1996,19:177.
-
10Imke C,Rodriguez B L,Grove J S,et al.Are remnant-like particles independent predictors of coronary heart disease incidence? The honolulu heart study[J].Arterioscler Thromb Vasc Biol,2005,25(8):1718-1722.
二级引证文献4
-
1银孟卓,卢建文.老年2型糖尿病患者的血清脂蛋白(a)水平及其与颈动脉硬化程度的关系[J].现代医院,2011,11(8):63-65. 被引量:6
-
2郑静,万翔,朱冬梅.apoB/apoA联合non—HDL—C检测对ACS患者主要心血管不良事件的预测价值[J].中国急救医学,2017,37(9):816-820. 被引量:3
-
3张汝强,马元平,吕品轶,刘萍,王芳.云南高原地区汉族人群心肌梗死患者危险因素分析[J].昆明医科大学学报,2017,38(6):68-72. 被引量:2
-
4王蓉,黄克亮,张建华,张欣.均相法检测脂蛋白残粒胆固醇的建立及初步临床应用[J].检验医学,2020,35(5):464-469. 被引量:1
-
1王乐如,谢佩蓉.血浆富含甘油三酯脂蛋白残粒与动脉粥样硬化研究进展[J].国外医学(临床生物化学与检验学分册),2000,21(6):294-296. 被引量:4
-
2徐成斌.问与答[J].英国医学杂志中文版,2007,10(6):386-386.
-
3王惠民,俞娟,孙承龙,张志泉,褚少朋,吴翔,徐耀忠,周锦红.PCR结合酶切和微流控电泳检测载脂蛋白CⅢ基因C-482T多态性[J].中华检验医学杂志,2008,31(1):94-96. 被引量:3
-
4郑平,祁哲.脂残粒的基础与临床[J].中国分子心脏病学杂志,2005,5(1):430-433. 被引量:2
-
5柯元南,段玉成.降低胆固醇与动脉粥样硬化的预防(二)[J].中老年保健,2016,0(2):8-9.
-
6田利华,吕建媛,吴慧敏.α-硫辛酸对2型糖尿病患者糖脂代谢的影响[J].临床荟萃,2014,29(4):447-448. 被引量:2
-
7张雪梅,刘秉文.载脂蛋白E研究进展[J].中国动脉硬化杂志,2001,9(2):165-168. 被引量:10
-
8秦英楠,李向平.载脂蛋白A5对甘油三酯代谢的影响及其机制[J].中国动脉硬化杂志,2010,18(6):415-418. 被引量:4
-
9曹志友,张文希.高甘油三酯血症致冠心病的研究进展[J].人民军医,2002,45(3):164-166. 被引量:6
-
10蒋兴亮,周京国,唐中,张均.冠心病患者血清残粒脂蛋白胆固醇变化及其临床意义的研究[J].中华心血管病杂志,2005,33(7):660-660. 被引量:3